Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

Diabetes

Volumn 50, Issue 8, 2001, Pages 1844-1850

  Marchesini, Giulio ^b   Brizi, Mara ^c   Blanchi, Giampaolo ^c   Tomassetti, Sara ^c   Bugianesi, Elisabetta ^c   Lenzi, Marco ^c   McCullough, Arthur J ^a   Natale, Stefania ^c   Forlani, Gabriele ^c   Melchionda, Nazario ^c  

^a METROHEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; AGED; ARTICLE; BLOOD; BODY CONSTITUTION; CARDIOVASCULAR DISEASE; DRUG EFFECT; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINISM; HYPERTENSION; INSULIN RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; LIPOLYSIS; LIVER; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; REFERENCE VALUE;

ADULT; AGED; BLOOD GLUCOSE; BODY CONSTITUTION; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; HYPERTENSION; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; LIPOLYSIS; LIVER; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 0035431018     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.8.1844     Document Type: Article

References (55)

1. Leevy CM: Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine 41:249-276, 1962
2. Stone BG, Van Thiel DH: Diabetes mellitus and the liver. Semin Liver Dis 5:8-28, 1985
3. Foster KJ, Griffith AH, Dewbury K, Price CP, Wright R: Liver disease in patients with diabetes mellitus. Postgrad Med J 56:767-772, 1980
4. Silverman JF, Pories WJ, Caro JF: Liver pathology in diabetes mellitus and morbid obesity: clinical, pathological, and biochemical considerations. Pathol Annu 24:275-302, 1989
5. Ludwig J, Viaggiano TR, McGill DB, Oh BJ: Nonalcoholic steatohepatitis: Mayo Clinic experience with a hitherto unnamed disease. Mayo Clin Proc 55:434-438, 1980
6. Wanless IR, Lentz JS: Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12:1106-1110, 1990
7. Eriksson S, Eriksson KF, Bondesson L: Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand 220:83-88, 1986
8. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW: The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11:74-80, 1990
9. Lee RG: Nonalcoholic steatohepatitis: a study of 40 patients. Hum Pathol 20:594-598, 1989
10. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA: Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107: 1103-1109, 1994
11. Itoh S, Yougel T, Kawagoe K: Comparison between non-alcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 82:650-654, 1987
12. Diehl AM, Goodman Z, Ishak KG: Alcoholic disease in nonalcoholics: a clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95:1056-1062, 1988
13. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastraenterology 116:1413-1419, 1999
14. Sheth SG, Gordon FD, Chopra S: Nonalcoholic steatohepatitis. Ann Intern Med 126:137-145, 1997
15. Falchuk KR, Fiske SC, Haggitt RC, Federman R, Trey C: Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology 78:535-541, 1980
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from plasma fasting glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
17. Marchesini G, Brizi M, Morselli Labate AM, Bianchi G, Bugianesi G, McCullough AJ, Forlani G, Melchionda N: Association of non-alcoholic fatty liver disease to insulin resistance. Am J Med 107:450-455, 1999
18. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
19. Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC: Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr 18:353-358, 1999
20. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
21. DeFronzo RA, Simonson D, Ferrannini E: Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 23:313-319, 1982
22. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care 20:1183-1197, 1997
23. National Diabetes Data Group: Classification and diagnosis of diabetes and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
24. Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F, Croce LS, Paoletti S, de Bernard B, Tiribelli C, Dalla Palma L: Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 27:108-113, 1997
25. Han TS, McNeill G, Seidell JC, Lean ME: Predicting intra-abdominal fat from anthropometric measures: the influence of stature. Int J Obes Relat Metab Disord 21:587-593, 1997
26. Feder JN, Gnirke A, Thomas W, Tsichihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintler GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK: A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 13:399-408, 1996
27. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Diabetes 36:914-924, 1987
28. Duncan DB: Multiple range test for correlated and heteroscedastic means. Biometrics 13:164-204, 1957
29. Hume R: Prediction of lean body mass from height and weight. J Clin Pathol 19:389-391, 1966
30. Lee JH, Rhee PL, Lee JK, Lee KT, Kim JJ, Koh KC, Paik SW, Lee WJ, Lim HK, Rhee JC: Role of hyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight. Korean J Intern Med 13:12-14, 1998
31. Reaven GM: Role of insulin resistance in human diabetes. Diabetes 37: 1595-1607, 1988
32. Ferrannini E, Natali A: Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J 121:1274-1282, 1991
33. Björntorp P: Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 4:622-627, 1988
34. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG: Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84:1513-1517, 1999
35. DeFronzo RA, Ferrannini E, Simonson DC: Fasting hyperglycemia in non-insulin dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-395, 1989
36. Marchesini G, Pacini G, Bianchi GP, Patrono D, Cobelli C: Glucose disposal, β-cell secretion, and hepatic insulin extraction in cirrhosis: a minimal model assessment. Gastroenterology 99:1715-1722, 1990
37. Wiesenthal SR, Sandhu H, McCall RH, Tchipashvili V, Yoshii H, Polonsky K, Shi ZQ, Lewis GF, Mari A, Giacca A: Free fatty acids impair hepatic insulin extraction in vivo. Diabetes 48:766-774, 1999
38. Goto T, Onuma T, Takebe K, Kral JG: The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Melab Disord 19:841-845, 1995
39. Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebowitz HE, Krai JG: Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord 19:846-850, 1995
40. Arner P: Not all fat is alike. Lancet 351:1301-1302, 1998
41. Day CP. James OFW: Steatohepatitis: a tale of two "hits." Gastroenterology 114:842-845, 1998
42. George DK, Goldwurm S, McDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW: Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114:311-318, 1998
43. Morimoto M, Hagbjork AL, Nanji AA, Ingelman-Sundberg M, Lindros KO, Fu PC, Albano E, French SW: Role of cytochrome P450 2E1 in alcoholic liver disease pathogenesis. Alcohol 10:459-464, 1993
44. Drenick EJ, Simmons F, Murphy JF: Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass. N Engl J Med 282:829-834, 1970
45. Ferrannini E: Insulin resistance, iron, and the liver. Lancet 355:2181-2182, 2000
46. Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y: A new syndrome of liver iron overload with normal transferrin saturation. Lancet 349:95-97, 1997
47. Mendler M-H, Turlin B, Moirand R, Jouanolle A-M, Sapey T, Guyader D, Le Gall J-Y, Brissot P, David V, Deugnier Y: Insulin resistance-associated hepatic iron overload. Gastroenterology 117:1155-1163, 1999
48. Britton RS: Metal-induced hepatotoxicity. Semin Liver Dis 16:3-12, 1996
49. Lee KS, Buck M, Houglum K, Chojkier M: Activation of hepatic stellate cells by TGF alpha and collagen type 1 is mediated by oxidative stress through c-myb expression. J Clin Invest 96:2461-2468, 1995
50. Bedossa P, Houglum K, Trautwein C, Holstege A, Chojkier M: Stimulation of collagen 1 (I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology 19:1262-1271, 1994
51. Berson A, De Beco V. Lettéron P, Robin MA, Moreau C, El Kahwaji J, Verthier N, Feldmann G, Fromenty B, Pessayre D: Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 114:764-774, 1998
52. Cotrim HP, Andrade ZA, Parana R, Portugal M, Lyra LG, Freitas LAR: Nonalcoholic steatohepatitis: a toxic liver disease in industrial workers. Liver 19:299-304, 1999
53. Kern PA, Saghizaheh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119, 1995
54. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN: Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120:1183-1192, 2001
55. Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM: Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 6:998-1003, 2000